Disorders of Adipose Tissue and Lipodystrophies: Causes, Consequences, and Treatment Perspectives

Lipodystrophies are rare metabolic disorders characterized by the loss of adipose tissue, which can manifest as generalized, partial, or localized. This condition is associated with metabolic complications such as insulin resistance, diabetes, hypertriglyceridemia, and liver steatosis. The paper di...

Full description

Saved in:
Bibliographic Details
Main Authors: Rosińska Kamila Rosińska, Ewelina Justyna Janicka, Julia Natalia Skibicka, Monika Niedźwiedzka, Mateusz Rosiński
Format: Article
Language:English
Published: Nicolaus Copernicus University in Toruń 2025-02-01
Series:Quality in Sport
Subjects:
Online Access:https://apcz.umk.pl/QS/article/view/58194
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823856435248758784
author Rosińska Kamila Rosińska
Ewelina Justyna Janicka
Julia Natalia Skibicka
Monika Niedźwiedzka
Mateusz Rosiński
author_facet Rosińska Kamila Rosińska
Ewelina Justyna Janicka
Julia Natalia Skibicka
Monika Niedźwiedzka
Mateusz Rosiński
author_sort Rosińska Kamila Rosińska
collection DOAJ
description Lipodystrophies are rare metabolic disorders characterized by the loss of adipose tissue, which can manifest as generalized, partial, or localized. This condition is associated with metabolic complications such as insulin resistance, diabetes, hypertriglyceridemia, and liver steatosis. The paper discusses the classification of lipodystrophies by etiology and fat loss extent, including generalized and partial forms, both congenital and acquired. Special focus is placed on HIV-associated lipodystrophy due to the prevalence of antiretroviral therapy. The pathophysiology involves disrupted adipogenesis, leading to abnormal fat distribution and metabolic dysfunction. Diagnosis includes medical history, physical exams, and body composition analysis. Treatment focuses on managing metabolic issues and may involve therapies like metreleptin. OBJECTIVE: This study aims to analyze the pathophysiology, diagnosis, and treatment of lipodystrophies, particularly focusing on congenital, acquired, and HIV-associated forms. It explores the underlying metabolic mechanisms, diagnostic challenges, and current and future therapeutic approaches, including metreleptin and other strategies. MATERIALS AND METHODS: The study relies on scientific research, review articles, and reports on lipodystrophy syndromes, primarily sourced from PubMed, Google Scholar, and Cochrane Library. It examines data related to diagnostics, etiology, and treatment options. CONCLUSIONS: Lipodystrophies are rare and heterogeneous, making diagnosis challenging. Early detection is essential to prevent complications like diabetes and cardiovascular disease. Modern technologies such as dual-energy X-ray absorptiometry (DEXA) help assess body composition more accurately. Although therapies like metreleptin show promise, they remain expensive and difficult to implement. Further research is needed to improve understanding and management of lipodystrophies, and patient education is crucial for better outcomes.
format Article
id doaj-art-7899f606db7b44c29ed6afdd8c5608d2
institution Kabale University
issn 2450-3118
language English
publishDate 2025-02-01
publisher Nicolaus Copernicus University in Toruń
record_format Article
series Quality in Sport
spelling doaj-art-7899f606db7b44c29ed6afdd8c5608d22025-02-12T08:26:13ZengNicolaus Copernicus University in ToruńQuality in Sport2450-31182025-02-013810.12775/QS.2025.38.58194Disorders of Adipose Tissue and Lipodystrophies: Causes, Consequences, and Treatment PerspectivesRosińska Kamila Rosińska0https://orcid.org/0009-0001-8158-2051Ewelina Justyna Janicka1https://orcid.org/0009-0006-5139-1728Julia Natalia Skibicka2https://orcid.org/0009-0000-1832-2938Monika Niedźwiedzka3https://orcid.org/0009-0004-9952-3414Mateusz Rosiński4https://orcid.org/0009-0009-6193-8282Voivodeship Integrated Hospital of Jędrzej Śniadecki in BialystokCOPERNICUS Medical Entity Sp. z o. o. Nowe Ogrody 1-6, 80-803 Gdańsk, Poland Grochowski Hospital, Grenadierów 51/59, 04-073 Warsaw, PolandMedical University of Bialystok, Jana Kilińskiego 1, 15-089 Białystok, PolandMedical University of Bialystok, Jana Kilińskiego 1, 15-089 Białystok, Poland Lipodystrophies are rare metabolic disorders characterized by the loss of adipose tissue, which can manifest as generalized, partial, or localized. This condition is associated with metabolic complications such as insulin resistance, diabetes, hypertriglyceridemia, and liver steatosis. The paper discusses the classification of lipodystrophies by etiology and fat loss extent, including generalized and partial forms, both congenital and acquired. Special focus is placed on HIV-associated lipodystrophy due to the prevalence of antiretroviral therapy. The pathophysiology involves disrupted adipogenesis, leading to abnormal fat distribution and metabolic dysfunction. Diagnosis includes medical history, physical exams, and body composition analysis. Treatment focuses on managing metabolic issues and may involve therapies like metreleptin. OBJECTIVE: This study aims to analyze the pathophysiology, diagnosis, and treatment of lipodystrophies, particularly focusing on congenital, acquired, and HIV-associated forms. It explores the underlying metabolic mechanisms, diagnostic challenges, and current and future therapeutic approaches, including metreleptin and other strategies. MATERIALS AND METHODS: The study relies on scientific research, review articles, and reports on lipodystrophy syndromes, primarily sourced from PubMed, Google Scholar, and Cochrane Library. It examines data related to diagnostics, etiology, and treatment options. CONCLUSIONS: Lipodystrophies are rare and heterogeneous, making diagnosis challenging. Early detection is essential to prevent complications like diabetes and cardiovascular disease. Modern technologies such as dual-energy X-ray absorptiometry (DEXA) help assess body composition more accurately. Although therapies like metreleptin show promise, they remain expensive and difficult to implement. Further research is needed to improve understanding and management of lipodystrophies, and patient education is crucial for better outcomes. https://apcz.umk.pl/QS/article/view/58194Lipodystrophyadipose tissue lossmetabolisminsulin resistancediabeteshypertriglyceridemia
spellingShingle Rosińska Kamila Rosińska
Ewelina Justyna Janicka
Julia Natalia Skibicka
Monika Niedźwiedzka
Mateusz Rosiński
Disorders of Adipose Tissue and Lipodystrophies: Causes, Consequences, and Treatment Perspectives
Quality in Sport
Lipodystrophy
adipose tissue loss
metabolism
insulin resistance
diabetes
hypertriglyceridemia
title Disorders of Adipose Tissue and Lipodystrophies: Causes, Consequences, and Treatment Perspectives
title_full Disorders of Adipose Tissue and Lipodystrophies: Causes, Consequences, and Treatment Perspectives
title_fullStr Disorders of Adipose Tissue and Lipodystrophies: Causes, Consequences, and Treatment Perspectives
title_full_unstemmed Disorders of Adipose Tissue and Lipodystrophies: Causes, Consequences, and Treatment Perspectives
title_short Disorders of Adipose Tissue and Lipodystrophies: Causes, Consequences, and Treatment Perspectives
title_sort disorders of adipose tissue and lipodystrophies causes consequences and treatment perspectives
topic Lipodystrophy
adipose tissue loss
metabolism
insulin resistance
diabetes
hypertriglyceridemia
url https://apcz.umk.pl/QS/article/view/58194
work_keys_str_mv AT rosinskakamilarosinska disordersofadiposetissueandlipodystrophiescausesconsequencesandtreatmentperspectives
AT ewelinajustynajanicka disordersofadiposetissueandlipodystrophiescausesconsequencesandtreatmentperspectives
AT julianataliaskibicka disordersofadiposetissueandlipodystrophiescausesconsequencesandtreatmentperspectives
AT monikaniedzwiedzka disordersofadiposetissueandlipodystrophiescausesconsequencesandtreatmentperspectives
AT mateuszrosinski disordersofadiposetissueandlipodystrophiescausesconsequencesandtreatmentperspectives